Succession Risk in Pharma Operations
What is succession risk?
Succession risk is the risk that a critical role cannot be handed over without a loss of output or quality when the person in it leaves, retires or is promoted. It is usually discussed for executives. In operations it matters just as much for the QA specialist who leads investigations or the planner who runs scheduling.
Why is it high in regulated operations?
Qualified roles take a long time to fill and longer to learn. A new Qualified Person, investigator or validation lead needs training, qualification and experience with the specific process before working alone. When the know-how is also undocumented, the handover depends on the outgoing person's goodwill and time.
How do you reduce succession risk?
By making the role less dependent on the person: document the process as it is actually done, train a second person before they are needed, and move routine coordination into systems. HDI shows which roles carry the most dependency and in which processes, so that succession planning starts where the exposure is.
Related terms
- Institutional knowledge loss: what is lost when succession fails.
- Key-person risk: the broader exposure.
- Cognitive dependency: where the undocumented know-how sits.